Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -59,851 | -42,479 | -18,555 | -56,671 | -39,192 |
| Depreciation Amortization | 5,747 | 3,715 | 1,658 | 2,360 | 969 |
| Accounts receivable | 66 | 41 | 43 | 26 | -245 |
| Other Working Capital | 298 | 4,875 | -287 | 6,960 | 8,491 |
| Other Operating Activity | 5,166 | 3,528 | 2,063 | 8,214 | 7,833 |
| Operating Cash Flow | $-48,574 | $-30,320 | $-15,078 | $-39,111 | $-22,144 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 67,308 | 47,144 | 24,000 | -65,592 | -78,625 |
| PPE Investments | -6,187 | -5,250 | -1,226 | -9,243 | -8,580 |
| Net Acquisitions | -199 | -200 | N/A | -10,251 | N/A |
| Investing Cash Flow | $60,922 | $41,694 | $22,774 | $-85,086 | $-87,205 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,375 | 13,035 | 28 | 5,477 | 5,478 |
| Financing Cash Flow | $17,375 | $13,035 | $28 | $5,477 | $5,478 |
| Beginning Cash Position | 19,310 | 19,310 | 19,310 | 138,030 | 138,030 |
| End Cash Position | 49,033 | 43,719 | 27,034 | 19,310 | 34,159 |
| Net Cash Flow | $29,723 | $24,409 | $7,724 | $-118,720 | $-103,871 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,574 | -30,320 | -15,078 | -39,111 | -22,144 |
| Capital Expenditure | -6,187 | -5,250 | -1,226 | -9,243 | -8,580 |
| Free Cash Flow | -54,761 | -35,570 | -16,304 | -48,354 | -30,724 |